Genentech, 23andMe, Inc. Ask Pts on Avastin to Spit for Science

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A little drool could go a long way for cancer research. At least that’s the message Genentech Inc. and 23andMe Inc. — the powerhouse biotech company and consumer-focused DNA analysis website — are spitting out. Backing the companies’ effort to enroll 1,000 people in a clever trial of the blockbuster cancer drug Avastin, Genentech produced a minute-long YouTube video portraying people in various settings spitting into plastic receptacles.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC